MedTrace Logo

Life Plans Intervention Study

NCT03215901 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 430

Last updated 2020-06-17

Study results available
· View outcomes & findings →

Summary

The mass provision of HIV treatment in rural KwaZulu-Natal, South Africa has raised adult life expectancy by 18 years since 2003. We will conduct a population-based survey to assess young adults' beliefs about HIV, HIV treatment, and expectations for the future in the era of mass HIV treatment. Thh investigators will conduct a randomized evaluation to assess whether a short video providing young adults with information on longevity gains from HIV treatment affects young adults survival expectations, hope for the future, and health and educational behaviours, including uptake of HIV testing, the study's primary outcome.

Conditions

  • HIV/AIDS
  • Chronic HIV Infection
  • Health Knowledge, Attitudes, Practice

Interventions

BEHAVIORAL

A Beautiful Future Video

Video delivering information on the longevity gains due to HIV treatment in the area.

BEHAVIORAL

Active Control Video

Video on another topic.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Africa Health Research Institute

    collaborator OTHER

  • Boston University

    lead OTHER

Principal Investigators

  • Jacob Bor, SD · Assistant Professor

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-06
Primary Completion
2017-12-14
Completion
2017-12-14

Countries

  • South Africa

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03215901 on ClinicalTrials.gov